The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How Hospitals Rank in Treating Childhood-Onset SLE

How Hospitals Rank in Treating Childhood-Onset SLE

October 6, 2015 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Generic_Practice_Management_500x270Evidence-based minimum standards for the care of patients with childhood-onset systemic lupus erythematosus (cSLE) are not consistently met in the U.S., Brazil and India. And there is a “lot of room for improvement,” according to the lead author of a new study published online in Arthritis Care & Research.

You Might Also Like
  • REF-Funded Research Provides Prognostic Information about Childhood-onset SLE
  • Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
  • The Rate of Disability in Pediatric Patients with SLE
Also By This Author
  • What Rheumatologists Are Paid

The first-of-its-kind study, “Initial  Benchmarking of the Quality of Medical Care of Childhood-Onset Systemic Lupus Erythematosus,”1 reviewed the medical records of 483 patients in seven tertiary pediatric rheumatology centers (four in the U.S., two in Brazil and one in India) to gauge adherence to 25 quality indicators established by the 2013 “International Consensus for Provisions of Quality-Driven Care in Childhood-Onset Systemic Lupus Erythematosus.”2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The results show a wide variance among U.S. centers in how they address lupus nephritis, bone health, vaccinations and transition planning. Access to kidney biopsies was lower in Brazil than in the U.S., and large institutions met standards more often than small centers.

Lead author Rina Mina, MD, a pediatric and adult rheumatologist at the Cincinnati Children’s Hospital Medical Center and the University of Cincinnati, says this first round of research provides a bird’s-eye view of performance and shines a light on the difficulties of daily practice in the pediatric rheumatology community.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Based on the study results, there are several quality indicators that all centers are doing well, such as performing recommended standard laboratory evaluation for children who newly carry the diagnosis of cSLE; initiation of therapy within one month of the diagnosis of proliferative lupus nephritis; prescription of angiotensin converting enzyme inhibitor or angiotensin receptor blockers in patients with >500 mg/day of proteinuria; regular laboratory surveillance for medication; and immunosuppressive medication usage in the setting of major neuropsychiatric systemic lupus erythematosus events,” Dr. Mina told The Rheumatologist via email.

Of the 25 quality indicators assessed, 14 (56%) displayed important differences at the U.S. sites.

“The largest variability was noted for quality indicators that address education on cardiovascular risks and calcium/vitamin D supplementation with glucocorticoid use,” Dr. Mina says. “In comparing small vs. large centers, there were statistically significant differences in observance of 13 of the 25 quality indicators (13/25=52%) assessed.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Richard Quinn is a freelance writer in New Jersey.

Reference

  1. Mina R, Harris JG, Klein-Gitelman MS, et al. Initial benchmarking of the quality of medical care of childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22666. [Epub ahead of print]
  2. Hollander MC, Sage JM, Greenler AJ, et al. International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013 Sep;65(9):1416–1423. doi: 10.1002/acr.21998.

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Arthritis & Rheumatology, childhood-onset SLE, hospital, Pediatric Rheumatology, systemic lupus erythematosus (SLE)

You Might Also Like:
  • REF-Funded Research Provides Prognostic Information about Childhood-onset SLE
  • Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
  • The Rate of Disability in Pediatric Patients with SLE
  • Silent Cardiac Impairment in SLE

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)